Olema Pharmaceuticals, Inc. OLMA
6.76 USD 0.00 (+0.00%)
At closeNov 6, 2026, 8:07 AM EST
7.19 +0.43 +6.38%
Pre-market · Nov 6, 8:07 AM ET
6.71 Day range 7.52
6.24 52-week range 36.26
- YTD
- -72.96%
- 1 year
- -14.97%
Financial health
Altman Z-Score
3.92 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -13.4×
FY 2018 5y median -5.2× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 4.5×
FY 2018 5y median 1.3× FY 2025
P/FCF -14.8×
FY 2018 5y median -7.1× FY 2025
EV/EBITDA -13.1×
FY 2018 5y median -5.1× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -6.7%
FY 2018 5y median -14.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -33.9%
FY 2018 5y median -33.9% FY 2025
ROIC -37.0%
FY 2018 5y median -37.0% FY 2025
ROA -30.5%
FY 2018 5y median -30.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -25.6%
FY 2018 FY 2025
EPS (diluted) 15.0%
FY 2018 FY 2025
Free Cash Flow -40.4%
FY 2018 FY 2025
Financial Health
Current Ratio 10.0×
FY 2018 5y median 12.3× FY 2025
Quick Ratio 10.0×
FY 2018 5y median 12.3× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31